Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
Adamson C, Kondo T, Jhund PS, de Boer RA, Cabrera Honorio JW, Claggett B, Desai AS, Alcocer Gamba MA, Al Habeeb W, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Langkilde AM, Lindholm D, Bachus E, Litwin SE, Martinez F, Petersson M, Shah SJ, Vaduganathan M, Nguyen Vinh P, Wilderäng U, Solomon SD, McMurray JJV. Adamson C, et al. Among authors: lam csp. Eur Heart J. 2022 Nov 1;43(41):4406-4417. doi: 10.1093/eurheartj/ehac481. Eur Heart J. 2022. PMID: 36029309 Free PMC article.
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS. Santhanakrishnan R, et al. Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5. Eur J Heart Fail. 2012. PMID: 22869458 Free article.
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW. Lam CS, et al. Circ Heart Fail. 2012 Sep 1;5(5):571-8. doi: 10.1161/CIRCHEARTFAILURE.112.970061. Epub 2012 Aug 10. Circ Heart Fail. 2012. PMID: 22887722 Free PMC article. Clinical Trial.
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.
Greene SJ, Shah AN, Butler J, Ambrosy AP, Anker SD, Chioncel O, Collins SP, Dinh W, Dunnmon PM, Fonarow GC, Lam CS, Mentz RJ, Pieske B, Roessig L, Rosano GM, Sato N, Vaduganathan M, Gheorghiade M. Greene SJ, et al. Am Heart J. 2014 Aug;168(2):142-9. doi: 10.1016/j.ahj.2014.05.009. Epub 2014 May 24. Am Heart J. 2014. PMID: 25066552 Free PMC article.
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
Senni M, Paulus WJ, Gavazzi A, Fraser AG, Díez J, Solomon SD, Smiseth OA, Guazzi M, Lam CS, Maggioni AP, Tschöpe C, Metra M, Hummel SL, Edelmann F, Ambrosio G, Stewart Coats AJ, Filippatos GS, Gheorghiade M, Anker SD, Levy D, Pfeffer MA, Stough WG, Pieske BM. Senni M, et al. Eur Heart J. 2014 Oct 21;35(40):2797-815. doi: 10.1093/eurheartj/ehu204. Epub 2014 Aug 7. Eur Heart J. 2014. PMID: 25104786 Free PMC article. Review.
Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
Wong LL, Armugam A, Sepramaniam S, Karolina DS, Lim KY, Lim JY, Chong JP, Ng JY, Chen YT, Chan MM, Chen Z, Yeo PS, Ng TP, Ling LH, Sim D, Leong KT, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Lam CS, Jeyaseelan K, Richards AM. Wong LL, et al. Eur J Heart Fail. 2015 Apr;17(4):393-404. doi: 10.1002/ejhf.223. Epub 2015 Jan 23. Eur J Heart Fail. 2015. PMID: 25619197 Free article.
667 results